𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia

✍ Scribed by Delphine Allard; Sabine Amsellem; Marianne Abifadel; Mélanie Trillard; Martine Devillers; Gérald Luc; Michel Krempf; Yves Reznik; Jean-Philippe Girardet; Alexandre Fredenrich; Claudine Junien; Mathilde Varret; Catherine Boileau; Pascale Benlian; Jean-Pierre Rabès

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
254 KB
Volume
26
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

Autosomal dominant hypercholesterolemia (ADH) is a frequent (1/500) monogenic inherited disorder characterized by isolated elevation of LDL leading to premature cardiovascular disease. ADH is known to result from mutations at two main loci: LDLR (encoding the low density lipoprotein receptor), and APOB (encoding apolipoprotein B100), its natural ligand. We previously demonstrated that ADH is also caused by mutations of the PCSK9 (proprotein convertase subtilisin/kexin type 9) gene that encodes Narc-1 (neural apoptosis-regulated convertase 1). However, the role of this novel disease locus as a cause of hypercholesterolemia remains unclear. In the present study, we analysed the PCSK9 coding region and intronic junctions in 130 adult or pediatric patients with ADH, previously found as being non LDLR/non APOB mutation carriers. Four novel heterozygous missense variations were found: c.654A>T (p.R218S), c.1070G>A (p.R357H), c.1405C>T (p.R469W), and c.1327G>A (p.A443T). All mutations were absent in 340 normolipidemic controls. Except for the A443T, all mutations are nonconservative and modify a highly conserved residue. Segregation with hypercholesterolemia is incomplete in one pedigree. Type and severity of hyperlipidemia and of cardiovascular disease could vary among subjects from the same family. Finally, the proband carrying the R357H mutation exhibited very high plasma cholesterol during pregnancy, whereas the proband carrying the p.R469W mutation exhibited a severe phenotype of hypercholesterolemia in combination with a LDLR mutation resulting from a frameshift at residue F382 (1209delC). These observations suggest that variations in PCSK9 are a rare cause of non LDLR/non APOB ADH (approximately 2.3%) and that additional environmental or genetic factors may contribute to the phenotype caused by PCSK9 missense mutations in humans.

📜 SIMILAR VOLUMES

Erratum: Novel mutations of the PCSK9 ge
Erratum: Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia
✍ Delphine Allard; Sabine Amsellem; Marianne Abifadel; Mélanie Trillard; Martine D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 18 KB

The original article to which this Erratum refers was published in Human Mutation 26: 497 (2005) In Table 2, the first footnote that reads "\*Associated with p.D347Y on the same allele." should read "\*Associated with p.D347Y." as it is not known if the two mutations are in cis or in trans.

Mutations of the EPHA2 receptor tyrosine
Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract
✍ Tianxiao Zhang; Rui Hua; Wei Xiao; Kathryn P. Burdon; Shomi S. Bhattacharya; Jam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

Congenital cataracts (CCs) are clinically and genetically heterogeneous. Mutations in the same gene may lead to CCs differing in inheritance, morphology and severity. Loci for autosomal dominant posterior polar CC and total CC have both been mapped to the chromosomal 1p36 region harboring the EPHA2

The molecular basis of familial hypercho
The molecular basis of familial hypercholesterolemia in Lebanon: Spectrum of LDLR mutations and role of PCSK9 as a modifier gene
✍ Marianne Abifadel; Jean-Pierre Rabès; Sélim Jambart; Georges Halaby; Marie-Hélèn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 1 views

Autosomal dominant hypercholesterolemia (ADH), a major risk for coronary heart disease, is associated with mutations in the genes encoding the low-density lipoproteins receptor (LDLR), its ligand apolipoprotein B (APOB) or PCSK9 (Proprotein Convertase Subtilin Kexin 9). Familial hypercholesterolemia

Distinct novel mutations affecting the s
Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families
✍ Suqin Chen; Chun Song; Hui Guo; Pingyi Xu; Weijun Huang; Yan Zhou; Jiandong Sun; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 1 views

## Communicated by Christine Van Broeckhoven Hereditary spastic paraplegia (HSP) is a neurodegenerative disease characterized by lower-limb spasticity, hyperreflexia, progressive spastic gait abnormalities, and an extensor-plantar response. It is genetically very heterogeneous, with 28 Human Genome